Pneumocystis jirovecii pneumonia in patients with lung cancer receiving immune checkpoint inhibitors: a retrospective nationwide population-based cohort study from South Korea
The incidence of PCP in patients with lung cancer treated with ICIs did not differ significantly from that in patients not treated with ICIs.
Authors
- Seong Yeon Park (ORCID: https://orcid.org/0000-0001-8762-7006)
- Dalyong Kim (ORCID: https://orcid.org/0000-0003-0193-422X)
- Kyoungmin Lee (ORCID: https://orcid.org/0000-0002-6578-7671)
- Sungim Choi (ORCID: https://orcid.org/0000-0001-8692-5570)
- Jiyun Jung (ORCID: https://orcid.org/0000-0002-8235-0316)
- Jae Yoon Park (ORCID: https://orcid.org/0000-0001-8986-7492)
- Hee Bum Jo
Institutions
- Korea University (KR)
- Dongguk University (KR)
- Dongguk University Ilsan Hospital (KR)
- Sejong General Hospital (KR)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-05-30
- DOI
- https://doi.org/10.1007/s12672-025-02627-8
- Citations
- 1
- Primary Topic
- Pneumocystis jirovecii pneumonia detection and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- Dongguk University
- Health Insurance Review and Assessment Service